The Treatment of Lung Involvement in Systemic Sclerosis
Systemic sclerosis (SSc) patients are often affected by interstitial lung disease (ILD) and, although there have been recent treatment advances, it remains the leading cause of death among SSc, with a 10-year mortality up to 40%. African Americans and subjects with diffuse cutaneous SSc or anti-topo...
Saved in:
Main Authors: | Barbara Ruaro (Author), Marco Confalonieri (Author), Marco Matucci-Cerinic (Author), Francesco Salton (Author), Paola Confalonieri (Author), Mario Santagiuliana (Author), Gloria Maria Citton (Author), Elisa Baratella (Author), Cosimo Bruni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
by: Barbara Ruaro, et al.
Published: (2021) -
Editorial: Pulmonary fibrosis: One manifestation, various diseases
by: Barbara Ruaro, et al.
Published: (2022) -
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
by: Barbara Ruaro, et al.
Published: (2022) -
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
by: Barbara Ruaro, et al.
Published: (2023) -
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review
by: Martina Orlandi, et al.
Published: (2022)